Literature DB >> 11960072

Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation.

Alex Yui Hui1, Henry Lik-yuen Chan, Nancy Wai-yee Leung, Lawrence Cheung-tsui Hung, Francis Ka-leung Chan, Joseph Jao-yiu Sung.   

Abstract

GOALS: To determine the 2-year survival and prognostic indicators of hepatitis B virus-related cirrhosis after the onset of hepatic decompensation.
BACKGROUND: Chronic hepatitis B (CHB) patients with cirrhosis and resultant hepatic decompensation have reduced survival. However, the natural history of these patients has not been well characterized in previous studies. Better understanding of survival and prognostic indicators is essential in management of these patients, especially in determining who should be candidates for orthotopic liver transplantation. STUDY: This is a retrospective longitudinal study of 96 patients with CHB-related cirrhosis after the onset of hepatic decompensation. The overall survival was ascertained, and clinical and laboratory variables were analyzed. Significant prognostic indicators for survival at 2 years were determined using univariate and multivariate analyses with Cox regression model.
RESULTS: The overall survival was 80% at 2 years after onset of decompensation. With univariate and multivariate analyses, hepatic encephalopathy and hypoalbuminemia less than 2.8 g/dL were significant prognostic indicators of poor survival probability. The hazard ratios were 5.22 (95% confidence interval, 1.67-16.3) and 8.57 (95% confidence interval, 1.94-37.8), respectively. Patients with hypoalbuminemia less than 2.8 g/dL had a 2-year survival of only 62%.
CONCLUSIONS: Our study showed that of CHB patients who developed the first episode of hepatic decompensation, those with hepatic encephalopathy or significant hypoalbuminemia or both have worse prognoses. They should be considered potential candidates for liver transplantation.

Entities:  

Mesh:

Year:  2002        PMID: 11960072     DOI: 10.1097/00004836-200205000-00018

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  23 in total

1.  Antiviral therapy for acute-on-chronic liver failure in chronic hepatitis B: is it too late?

Authors:  Henry Lik-Yuen Chan
Journal:  Dig Dis Sci       Date:  2010-08       Impact factor: 3.199

2.  The effectiveness of lamivudine treatment in cirrhotic patients with HBV precore mutations: a prospective, open-label study.

Authors:  Cengiz Bolukbas; Fusun Filiz Bolukbas; Tulin Kendir; Nihat Akbayir; Ali Tuzun Ince; Evren Abut; Mehmet Horoz; Ali Remzi Dalay; Mehmet Haci Sokmen; Oya Ovunc
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 3.  Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy.

Authors:  Vicente Felipo
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

4.  Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study.

Authors:  Yi-Cheng Chen; Chia-Ming Chu; Chau-Ting Yeh; Yun-Fan Liaw
Journal:  Hepatol Int       Date:  2007-03       Impact factor: 6.047

5.  Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China.

Authors:  Weixia Ke; Chi Zhang; Li Liu; Yanhui Gao; Zhenjiang Yao; Xiaohua Ye; Shudong Zhou; Yi Yang
Journal:  Hepatol Int       Date:  2016-06-07       Impact factor: 6.047

6.  Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China.

Authors:  Keng Lai; Chi Zhang; Weixia Ke; Yanhui Gao; Shudong Zhou; Li Liu; Yi Yang
Journal:  Clin Drug Investig       Date:  2017-03       Impact factor: 2.859

7.  Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.

Authors:  Carmina Montoliu; Blanca Piedrafita; Miguel A Serra; Juan A del Olmo; Antonio Ferrandez; José M Rodrigo; Vicente Felipo
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

8.  Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients.

Authors:  Wei Li; Ning Li; Rui Wang; Qunhui Li; Hao Wu
Journal:  Hepatol Int       Date:  2015-03-21       Impact factor: 6.047

9.  Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications.

Authors:  L Benvegnù; M Gios; S Boccato; A Alberti
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

10.  Quantitative multivoxel 1H MR spectroscopy of the brain in children with acute liver failure.

Authors:  Paul E Sijens; Heyder Alkefaji; Roelineke J Lunsing; Francjan J van Spronsen; Linda C Meiners; Matthijs Oudkerk; Henkjan J Verkade
Journal:  Eur Radiol       Date:  2008-05-21       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.